Health

Prescriptions for Eli Lilly’s new weight-loss drug get off to a strong start and confirm bright outlook


The launch of Eli Lilly‘s weight-loss drug Zepbound — a key pillar of our investment thesis in the pharmaceuticals giant — is going swimmingly in the U.S., Jefferies said Friday.



READ SOURCE

This website uses cookies. By continuing to use this site, you accept our use of cookies.